📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pharmacogenetics of artemether-lumefantrine influence on nevirapine disposition: Clinically significant drug-drug interaction? (2019)

First Author: Abdullahi ST

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bcp.13821

PubMed Identifier: 30471138

Publication URI: http://europepmc.org/abstract/MED/30471138

Type: Journal Article/Review

Volume: 85

Parent Publication: British journal of clinical pharmacology

Issue: 3

ISSN: 0306-5251